In-house: AI patenting is becoming more challenging
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house: AI patenting is becoming more challenging

ai.JPG

Panellists at the Managing IP US Patent Forum delved into the complexities and challenges of patenting artificial intelligence as the technology evolves

Despite some governments taking huge steps to try to understand the complexities of artificial intelligence and intellectual property, there is still a lot of uncertainty surrounding what firms can patent, as emphasised by one panel at Managing IP’s US Patent Forum on Wednesday.

For starters, as speakers from Medtronic, Aptiv and Sterne Kessler pointed out, different organisations have different ideas of what AI actually is.

“For us, as a healthcare company, regular software receives specific instructions that tell it how to behave, classify data and make decisions,” said Ishak Akyuz, senior principal legal counsel at Medtronic in New York City.

“For AI, we start thinking of providing a framework for the computer to make decisions and draw conclusions without providing specific instructions. It becomes like a black box where we don’t actually know how the computer is coming up with decisions that classifies something as X or Y.”

David Goodfellow, EMEA chief patent counsel at technology company Aptiv in Dublin, added that his business and other AI-focused companies were well positioned to manage software patents, which they could now expect to properly scope to make eligible and meaningful in most jurisdictions.

But now, AI patenting has morphed from dealing with software into managing machine learning and big data, pushing that through neural networks and then trying to patent the results of that process.

“It’s now a matter of what you have learned from that machine learning and how it is applied by the machine, the results of that learning, and trying to claim that,” Goodfellow said.

He added that he had approached this shift in the same way as for general software patenting, where a technical result is required. A business should get a patent so long as the method of the AI engine or model is carried out by technical or real-world hardware, he said.

“It cannot not just be a case of pushing data around or manipulating it,” he noted.

What you can protect

Goodfellow added that the real difficulty in patenting AI in different jurisdictions is finding the nexus of a claim. He asked: “Who is possibly going to infringe the resulting claim, particularly in a distributed computing environment that a lot of AI is using?

“It’s pulling in data from different places and training the models, which might be sitting somewhere else along with the data. The actual number crunching might be somewhere else too.”

He added: “Actually determining the one infringer of the claim, then, is interesting. That question itself is not necessarily answered in a lot of jurisdictions, because we simply haven’t been testing these patents yet.”

On the question of where it might be best to patent or not, he saidthe answer always comes back to why a counsel is patenting an AI product.

“Are you patenting to have something that’s enforceable against someone who might be impacting on your market? If so, you want the patent in the market and you need to frame it so it is operable and can find infringers in that market.”

He added that startups or SMEs, which could just be looking for investment, might want to make sure they’ve got some patents behind the technology they’re looking to develop so they can push to get some investors or customers.

Akyuz at Medtronic added that he tends to take a different approach to jurisdictional patenting.

“For us, we’re talking about machine learning, and those models have been around for years. The best models are open source software, so anyone can use them.

“But when you’re looking to achieve 99% or 99.91% accuracy, or higher, that’s really where just using the base models is really not going to be sufficient.”

He added: “Then we need to think outside the box and look at the inputs and outputs of those models and look at where we can boost the accuracy – at which point you have to consider how you are going to prove that someone is infringing your patents.”

Akyuz said that, for Medtronic, it’s a matter of whether something in the project is easily observable and can form the basis of an infringement suit.

more from across site and ros bottom lb

More from across our site

Sources debate the implications of an opinion by Delaware’s chief judge Colm Connolly that lambasted the NPE IP Edge
Five partners reveal how delays in examining trademark applications are affecting their advice to clients and how they pitch new work
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Partners at Quinn Emanuel explain how walkie-talkie and real-estate analogies helped them win over a jury at the Eastern District of Texas
The heads of Malaysian firm HHQ’s new technology practice group say they can be frontline advisers on the intersection between AI, blockchain, and IP
Darren Jiron, Finnegan’s managing partner in London, discusses the firm’s growth plans and misconceptions about US firm culture
The EMEA region research cycle has commenced - do not miss this opportunity to nominate your work from 2023!
A former partner at Stroock & Stroock & Lavan, which voted to dissolve in October, has joined McCarter & English
As ChatGPT celebrates its first birthday, we are still grappling with a multitude of IP concerns
Sources say an official role at an IP industry body is great for generating business leads, but that shouldn’t be the only motivation behind taking on the responsibility